Andreas Halvorsen – NAMS history
- Issuer:
- NEWAMSTERDAM PHARMA COMPANY
- Quarters tracked:
- 17 (Q4 2022 → Q1 2026)
- Current shares:
- 4,203,567
- Current value:
- $134.56M
- Peak shares:
- 8,024,565 (Q3 2023)
- Overall change:
- +12%
| Quarter | Shares | Value | $/Share | Share Δ | Δ% |
|---|---|---|---|---|---|
| Q1 2026 | 4,203,567 | $134.56M | $32.01 | 0 | 0% |
| Q4 2025 | 4,203,567 | $147.46M | $35.08 | -2,271,967 | -35% |
| Q3 2025 | 6,475,534 | $184.16M | $28.44 | -503,000 | -7% |
| Q2 2025 | 6,978,534 | $126.38B | $18110.00 | 0 | 0% |
| Q2 2025 | 6,978,534 | $126.38M | $18.11 | 0 | 0% |
| Q1 2025 | 6,978,534 | $142.85M | $20.47 | 0 | 0% |
| Q1 2025 | 6,978,534 | $142.85B | $20470.00 | 0 | 0% |
| Q4 2024 | 6,978,534 | $179.35M | $25.70 | 0 | 0% |
| Q4 2024 | 6,978,534 | $179.35B | $25700.00 | -1,046,031 | -13% |
| Q3 2024 | 8,024,565 | $133.21M | $16.60 | 0 | 0% |
| Q2 2024 | 8,024,565 | $154.15M | $19.21 | 0 | 0% |
| Q1 2024 | 8,024,565 | $189.78M | $23.65 | 0 | 0% |
| Q4 2023 | 8,024,565 | $89.63B | $11170.00 | 0 | 0% |
| Q3 2023 | 8,024,565 | $74.23B | $9250.00 | +1,500,000 | +23% |
| Q2 2023 | 6,524,565 | $77.58B | $11890.00 | +2,608,695 | +67% |
| Q1 2023 | 3,915,870 | $52.63B | $13440.00 | +162,042 | +4% |
| Q4 2022 | 3,753,828 | $39.49M | $10.52 | — | NEW |